2019: Articles in Press
Letter to Editor
Published
March 7, 2019
Copyright (c) 2019 Sanchez A
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Bisphosphonates (BP) are the most commonly used medications for the treatment of osteoporosis. Of them, the most frequently prescribed worldwide is alendronate. Of the various compounds available, those that are ingested are usually indicated, but they are also available for intravenous use at different intervals, depending on their potency [1].